Topical Vitamin C Solution Cleared Skin Cancer Lesions
A clinical study found that a high-concentration ascorbic acid solution effectively reduced skin cancer lesions.
Updated on Sept. 29, 2026 in Cancer
Live Poll
Would you consider trying experimental topical treatments before proceeding with surgery for diagnosed skin cancer?
In a recent clinical study, 56% of biopsy-confirmed squamous cell carcinoma in situ lesions achieved complete histologic clearance after topical treatment. The application of the solution allowed 94% of patients to avoid surgical excision.
Why it matters
High concentrations of ascorbic acid act as a pro-oxidant within tumor tissue, creating oxidative stress that can damage cancer cells. This suggests a potential non-invasive alternative to traditional surgical removal for certain skin cancer cases.
A study of 17 patients showed that applying a 30% ascorbic acid solution resulted in a 71% reduction in mean lesion area, decreasing from 1.06 cm² to 0.30 cm². While 56% of lesions achieved clearance, 44% shrank by more than 85%.
The details
Participants applied a solution containing 30% ascorbic acid, 95% DMSO, and 5% distilled water twice daily using a small brush. The DMSO was utilized to temporarily modify the lipid structure of the skin barrier, facilitating deeper penetration of the vitamin C.
Timeline
Participants applied the topical treatment twice daily for a duration of 12 weeks.
The Big Picture
This study follows a pattern set by research into the development of topical chemotherapeutic agents for non-melanoma skin cancer by utilizing solvent-enhanced penetration. The approach attempts to shift the paradigm away from surgical intervention toward localized, chemical-based treatment.
This research suggests a future where patients might avoid surgical procedures for certain types of skin cancer. However, patients should not attempt this regimen at home, as the study requires medical oversight and larger randomized trials to confirm safety and efficacy.
The takeaway
While these results offer promise for non-surgical skin cancer management, they currently represent an early-stage finding rather than a standardized medical treatment. Patients should continue to consult dermatologists for conventional care until broader clinical data is established.
Further reading
Learn more about evolving treatment options in our Cancer section.
Source note: This article includes information reported by Todayville.
Live Poll
Would you consider trying experimental topical treatments before proceeding with surgery for diagnosed skin cancer?
